Does Nurse Semi Structured Interview Added to a rTMS Improve Patients With Major Depressive Disorder?

NCT ID: NCT03436823

Last Updated: 2023-01-20

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

50 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-03-19

Study Completion Date

2023-01-06

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Repeated Transcranial Magnetic Stimulation - R.TMS - is currently part of the treatment for depressive illness. This non-invasive technique is designed to stimulate certain areas of the cerebral cortex involved in this pathology. FDA approved this treatment in routine for depressive illness. R.TMS still remains in assessment. Due to the heterogeneity of methods and the weakness of the cohorts therapeutic superiority can not concluded .

Stimulation parameters remain numerous even if a consensus is beginning to emerge. The therapeutic target is the left dorso - lateral prefrontal cortex. The lack of efficacy is probably due of the inaccuracy. The empirically location of the target does not take into account the inter-individual anatomical differences. The neuronavigation is becoming widespread in routine clinical practice.

The referent nurse stays with the patient all along the rTMS sessions. His role is to set up treatment, to ensure the safety and the well-being of the patient. An rTMS session is an average of 30 minutes and is a very special moment to create a specific therapeutic relationship.

No study was conducted to evaluate the therapeutic relationship. The assumption is made that rTMS with a semi - structured interview provides a qualitative and quantitative clinical response greater than a semi - structured rTMS without this nursing care. The investigators therefore propose to patients not receiving a semi-structured interview to listen to music with eyes closed.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Repeated Transcranial Magnetic Stimulation - R.TMS - is currently part of the treatment for depressive illness. This non-invasive technique is designed to stimulate certain areas of the cerebral cortex involved in this pathology. The Food \& Drug Administration - FDA - approved this treatment in routine for depressive illness. R.TMS still remains in assessment. Due to the heterogeneity of methods and the weakness of the cohorts therapeutic superiority can not concluded . Stimulation parameters remain numerous even if a consensus is beginning to emerge. The therapeutic target is the left dorso - lateral prefrontal cortex. The lack of efficacy is probably due of the inaccuracy. The empirically location of the target does not take into account the inter-individual anatomical differences. The neuronavigation is becoming widespread in routine clinical practice.

The referent nurse stays with the patient all along the rTMS sessions. His role is to set up treatment, to ensure the safety and the well-being of the patient. An rTMS session is an average of 30 minutes and is a very special moment to create a specific therapeutic relationship. To our knowledge, no study was conducted to evaluate the therapeutic relationship. The assumption is made that rTMS with a semi - structured interview provides a qualitative and quantitative clinical response greater than a semi - structured rTMS without this nursing care. The investigators, therefore propose to patients not receiving a semi-structured interview to listen to music with eyes closed.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Depressive Disorder, Major

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

R.TMS + nurse semi-structured interview

Repeated Transcranial Magnetic Stimulation sessions associated with nurse semi-structured interview

Group Type EXPERIMENTAL

nurse semi-structured interview

Intervention Type OTHER

The first session of rTMS is D1. From the first meeting to D14 semi -structured interviews are set up

R.TMS + Music & Relaxation

Repeated Transcranial Magnetic Stimulation sessions associated with music listening \& relaxation with eyes closed

Group Type SHAM_COMPARATOR

Music & Relaxation with eyes closed

Intervention Type OTHER

The first session of rTMS is D1. From the first meeting to D14 music \& relaxation with eyes closed sessions are set up

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

nurse semi-structured interview

The first session of rTMS is D1. From the first meeting to D14 semi -structured interviews are set up

Intervention Type OTHER

Music & Relaxation with eyes closed

The first session of rTMS is D1. From the first meeting to D14 music \& relaxation with eyes closed sessions are set up

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients volunteers aged 18 to 70,
* With the diagnosis of major depression, recurrent under the criteria of DSM.V,
* With an unmodified antidepressant treatment for 3 weeks,
* With a MADRS score greater than or equal to 21,
* With or without neuronavigated rTMS sessions,
* Informed and who have signed a consent.

Exclusion Criteria

* Patients with psychotic symptoms,
* With alcohol dependence or other substances abuse,
* With the strength criteria defined by the V stage for Classification of Thase \& Rush,
* Hospitalized without consent / or under legal protection for major.
* With a high risk of suicide - item 10 of the MADRS\> 3 in the absence of hospitalization,
* With contraindications to the practice of MRI or rTMS due to previous seizures, neurological disorders and / or neurosurgical, metal prosthetic presence or foreign bodies pacemaker type intraocular ferromagnetic material,
* Aged over 70 years due to cortical alteration,
* Pregnancy.
Minimum Eligible Age

18 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Ministry of Health, France

OTHER_GOV

Sponsor Role collaborator

Rennes University Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Dominique Drapier, MD

Role: PRINCIPAL_INVESTIGATOR

Centre Hospitalier Guillaume Régnier,

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

CHGR

Rennes, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

35RC14_9783_DESTIMCARE

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Using rTMS to Treat Depression
NCT05424224 ACTIVE_NOT_RECRUITING
rTMS for Depression
NCT06484413 COMPLETED
Improving Brain Stimulation Through Imaging
NCT03851380 ACTIVE_NOT_RECRUITING